Involvement of wild-type p53 in pre-B-cell differentiation in vitro
- PMID: 1924360
- PMCID: PMC52635
- DOI: 10.1073/pnas.88.20.8982
Involvement of wild-type p53 in pre-B-cell differentiation in vitro
Abstract
Wild-type p53 protein is a growth modulator whose inactivation has been found to be a key event in malignant transformation. Reconstitution of wild-type p53 in the p53-nonproducer, Abelson murine leukemia virus-transformed pre-B-cell line L12 gave rise to stably growing clones. Wild-type p53-producer derived cell lines exhibit an altered cell cycle, however. More cells with an extended G0/G1 phase were found than in the p53-nonproducer parental cell line. Furthermore, when injected into syngeneic mice, these cells induced a lower incidence of tumors and these tumors were less aggressive. Analysis of immunoglobulin expression revealed that wild-type p53 induced the expression of cytoplasmic immunoglobulin mu heavy chain. In addition, these derived cells lines exhibited increased levels of a B-cell-specific surface marker, B220. These results suggest that wild-type p53 may function as a cell differentiation factor that can induce development of pre-B cells into a more advanced stage in the pathway of B-cell maturation. In these pre-B cells, wild-type p53 may induce cell differentiation without terminal growth arrest of the cell population.
Similar articles
-
Identification of a novel bone marrow-derived B-cell progenitor population that coexpresses B220 and Thy-1 and is highly enriched for Abelson leukemia virus targets.Mol Cell Biol. 1989 Jun;9(6):2665-71. doi: 10.1128/mcb.9.6.2665-2671.1989. Mol Cell Biol. 1989. Retraction in: Mol Cell Biol. 1996 Oct;16(10):5946. doi: 10.1128/MCB.16.10.5946. PMID: 2474759 Free PMC article. Retracted.
-
Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.Cell. 1984 Aug;38(1):119-26. doi: 10.1016/0092-8674(84)90532-4. Cell. 1984. PMID: 6088057
-
Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins.Cancer Res. 1991 Oct 1;51(19):5232-7. Cancer Res. 1991. PMID: 1717142
-
Fidelity and infidelity in commitment to B-lymphocyte lineage development.Immunol Rev. 2000 Jun;175:104-11. Immunol Rev. 2000. PMID: 10933595 Review.
-
Conventional and Ly-1 B-cell lineages in normal and mu transgenic mice.Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:219-25. doi: 10.1101/sqb.1989.054.01.027. Cold Spring Harb Symp Quant Biol. 1989. PMID: 2517920 Review. No abstract available.
Cited by
-
Genome-wide analysis of the p53 gene regulatory network in the developing mouse kidney.Physiol Genomics. 2013 Oct 16;45(20):948-64. doi: 10.1152/physiolgenomics.00113.2013. Epub 2013 Sep 3. Physiol Genomics. 2013. PMID: 24003036 Free PMC article.
-
The murine C'-terminally alternatively spliced form of p53 induces attenuated apoptosis in myeloid cells.Mol Cell Biol. 1997 Feb;17(2):713-22. doi: 10.1128/MCB.17.2.713. Mol Cell Biol. 1997. PMID: 9001225 Free PMC article.
-
Interference with p53 protein inhibits hematopoietic and muscle differentiation.J Cell Biol. 1996 Jul;134(1):193-204. doi: 10.1083/jcb.134.1.193. J Cell Biol. 1996. PMID: 8698814 Free PMC article.
-
Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma.Indian J Med Res. 2016 May;143(Supplement):S23-S31. doi: 10.4103/0971-5916.191747. Indian J Med Res. 2016. PMID: 27748274 Free PMC article.
-
Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest.EMBO J. 1992 Jun;11(6):2115-21. doi: 10.1002/j.1460-2075.1992.tb05270.x. EMBO J. 1992. PMID: 1600943 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous